BioMarker Strategies has developed the SnapPathTM system, using significant funding support from the National Cancer Institute, to enable next-generation biomarker tests for cancer.

Jan 13, 2010 · BioMarker Strategies has developed its novel SnapPath® live tumor cell processing system to generate PathMAPTM profiles of solid tumors to promote improved …

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fresh …

The live cell biopsies were processed on the SnapPathTM live-tumor-cell platform (BioMarker Strategies, LLC) to modulate tumor cell signal transduction networks through brief exposure to …